Thank you, Peter, and welcome everyone. 2017 is off to a great start with a stronger-than-expected quarter. I would like to first highlight some of last quarter’s financial accomplishments and then finish with our view of the coming quarter. Turning to the Q1 results, net sales came in at €1.94 billion. Net system sales accounted for €1.22 billion, nicely balanced between logic and memory. With the addition of HMI products, we are now including metrology and inspection equipment in the system sales. We’re just previously reporting it as service and field option revenue. This also means that metrology and inspection systems orders are now from onwards included in our booking and backlog numbers. This provides more visibility of our current and future system business in this product group. Net service and field option sales for the quarter came in much stronger than expected at a level of €728 million, driven by major DUV and Holistic Lithography upgrades. As noted, YieldStar and HMI system revenue are now reported in net system revenue otherwise the service and field option revenue would have been even higher at approximately €790 million. Our gross margin for the quarter came in at 47.6%, slightly higher than guided, driven by a higher top-line and favorable mix. Gross margin includes the amortization of intangibles as well as the effect from the fair-value assessment of HMI’s inventory as of the closing date of the acquisition. Overall, OpEx came in as guided, although R&D expenses came in slightly lower at €315 million and SG&A expenses came in slightly higher at €99 million. Moving on to the order book, Q1 system bookings came in at €1.9 billion including orders for three 3400 EUV systems from two customers. Strong bookings continued in the logic sector in support of the 10 nanometer RAMs, and in support of the EUV insertion at the 7 nanometer node. Memory bookings strengthened further from its strong Q4 level, supporting expected year-on-year growth in the memory sector in 2017. The continuing order flow for EUV systems increases our EUV backlog with 21 systems valued at €2.3 billion. Our overall systems backlog now stands at €4.5 billion. In addition, we offer four EUV upgrade orders valued at approximately €200 million. This will bring these four NXE systems to NXE:3400 performance. In total, we have 14 3300 and 3350 systems in the field, which are candidate for upgrades. As a reminder, system upgrades are not included in our system backlog. Turning to the balance sheet, quarter-over-quarter cash, cash equivalents and short-term investments came in at €3.84 billion. As already mentioned in January, we saw a significant level of early payments from customers in Q4 of last year, which resulted in a negative free cash flow of €212 million in Q1. As a reminder in Q2, we have several extraordinary cash outflows, which will bring the overall cash balance back to our target level. Assuming approval at our AGM, we will pay a dividend of €1.20 per ordinary share or approximately €515 million in total to shareholders. We also have bond maturing in Q2 with an outstanding value of €238 million. And lastly, we expect to close the acquisition of 24.9% of Carl Zeiss SMT, during the quarter for €1 billion. Based on our current business view, we see a continued strong demand for DUV, Holistic Lithography and EUV products throughout the year in both memory and logic. Our view is supported by our highest backlog ever. With that, I would like to turn to our expectations and guidance for the second quarter of 2017. We expect continuing sales trends in Q2 with total net sales between €1.9 billion and €2 billion, including an estimated €200 million of EUV revenue. We plan to ship three NXE:3400 in the June quarter. Our EUV shipment plan for the full year includes 12 systems and is backend loaded. We expect our Q2 service and field options revenue to again came in above €650 million, driven by continued demand for Holistic Lithography options, high value upgrades, and our growing installed base. Gross margin for Q2 is expected to be between 43% and 44%, driven by the recognition of EUV system revenue, excluding the EUV revenue, gross margin would be approximately at the same level as Q1. Q2 gross margin also continues to carry the effect from the purchase price allocation for the HMI acquisition. The negative impact of these purchase price allocation adjustment for Q2 is more than one percentage point. The impact for the full fiscal year is about €90 million and will reduce to about €40 million per year from 2018 onwards. R&D expenses for Q2 will be about €315 million and SG&A is expected to come in at about €100 million. As a reminder, our share buyback program remains paused for the time being as we close our planned equity investment in Carl Zeiss SMT. The remaining approval from China is expected in time to close the transaction in Q2 2017. And finally, as mentioned before an increase of our annual dividend from €1.05 to €1.20 is submitted for approval at our annual general meeting of shareholders on April 26. With that, I’d like to turn the call back over to you, Peter.